{"id":46302,"date":"2022-07-19T12:01:58","date_gmt":"2022-07-19T10:01:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/"},"modified":"2022-07-19T12:01:58","modified_gmt":"2022-07-19T10:01:58","slug":"cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/","title":{"rendered":"Cardiomyopathies Epidemiology Forecasts\/Analysis Report 2021-2031: Focus on United States, France, Germany, Italy, Spain, UK, and Japan &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5632229\/cardiomyopathies-epidemiology-forecast-2021-2031?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=zxbcdd&amp;utm_campaign=1727949+-+Cardiomyopathies+Epidemiology+Forecasts%2FAnalysis+Report+2021-2031%3A+Focus+on+United+States%2C+France%2C+Germany%2C+Italy%2C+Spain%2C+UK%2C+and+Japan&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Cardiomyopathies Epidemiology Forecast, 2021-2031&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220719005671\/en\/1517453\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220719005671\/en\/1517453\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe report includes a 10-year epidemiological forecast for the diagnosed prevalent cases of these cardiomyopathies segmented by subtype, sex, and age (under 18 years, 18-29 years, and by 10-year age groups for ages 30 years up to 80 years and older) in these markets. The diagnosed prevalent cases are further segmented by causes (acquired versus inherited) and ischemic cases (DCM only).\n<\/p>\n<p>\nIn the 7MM, the diagnosed prevalent cases of cardiomyopathies will increase from 2,268,240 cases in 2021 to 2,852,506 cases in 2031, at an annual growth rate (AGR) of 2.58% per year. The diagnosed prevalent cases of cardiomyopathies in the five major European markets (5EU) (France, Germany, Italy, Spain, and the UK) will increase at an AGR of 1.43%, from 366,582 cases in 2021 to 419,183 cases in 2031.\n<\/p>\n<p>\nWhen examining the AGR by individual markets, the publisher estimates that the US will have the highest number of cases of cardiomyopathies in 2031, with 2,385,118 cases at an AGR of 2.87%. Conversely, Japan will have the least number of cases by 2031, with 48,205 cases at a negative AGR of 0.10%.\n<\/p>\n<p>\n<strong>Scope<\/strong>\n<\/p>\n<ul>\n<li>\nThe cardiomyopathies epidemiology report provides an overview of the risk factors, comorbidities, and global and historical trends for cardiomyopathies (DCM, HCM, RCM, and ARCM) in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan).\n<\/li>\n<li>\nThe report includes a 10-year epidemiological forecast for the diagnosed prevalent cases of cardiomyopathies segmented by subtype, sex, and age (under 18 years, 18-29 years, and by 10-year age groups for ages 30 years up to 80 years and older) in these markets. The diagnosed prevalent cases are further segmented by causes (acquired versus inherited) and ischemic cases (DCM only).\n<\/li>\n<li>\nThe epidemiology report provides additional clinically relevant segmentations for the diagnosed prevalent cases of cardiomyopathies including subtype specific etiology\n<\/li>\n<li>\nThe cardiomyopathies epidemiology report is written and developed by Masters- and PhD-level epidemiologists.\n<\/li>\n<li>\nThe Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in cardiomyopathies.\n<\/li>\n<\/ul>\n<p>\n<strong>The Cardiomyopathies Epidemiology series will allow you to:<\/strong>\n<\/p>\n<ul>\n<li>\nDevelop business strategies by understanding the trends shaping and driving the global cardiomyopathies markets.\n<\/li>\n<li>\nQuantify patient populations in the global cardiomyopathies markets to improve product design, pricing, and launch plans.\n<\/li>\n<li>\nOrganize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for cardiomyopathies therapeutics in each of the markets covered.\n<\/li>\n<li>\nUnderstand magnitude of the population with cardiomyopathies by age, sex, etiology, and ischemia (DCM only).\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Cardiomyopathies: Executive Summary<\/strong>\n<\/p>\n<p>\n1.1 Related Reports\n<\/p>\n<p>\n1.2 Upcoming Reports\n<\/p>\n<p>\n<strong>2 Epidemiology<\/strong>\n<\/p>\n<p>\n2.1 Disease Background\n<\/p>\n<p>\n2.1.1 Risk Factors and Comorbidities\n<\/p>\n<p>\n2.2 Global and Historical Trends\n<\/p>\n<p>\n2.3 Forecast Methodology\n<\/p>\n<p>\n2.3.1 Sources\n<\/p>\n<p>\n2.3.2 Forecast Assumptions and Methods\n<\/p>\n<p>\n2.3.3 Diagnosed Prevalent Cases of Dilated Cardiomyopathy\n<\/p>\n<p>\n2.3.4 Diagnosed Prevalent Cases of Hypertrophic Cardiomyopathy\n<\/p>\n<p>\n2.3.5 Diagnosed Prevalent Cases of Restrictive Cardiomyopathy\n<\/p>\n<p>\n2.3.6 Diagnosed Prevalent Cases of Arrhythmogenic Cardiomyopathy\n<\/p>\n<p>\n2.3.7 Diagnosed Prevalent Cases of Cardiomyopathies by Etiology\n<\/p>\n<p>\n2.3.8 Diagnosed Prevalent Cases of Dilated Cardiomyopathy with Ischemia\n<\/p>\n<p>\n2.4 Epidemiological Forecast for Cardiomyopathies (2021-2031)\n<\/p>\n<p>\n2.4.1 Diagnosed Prevalent Cases of Cardiomyopathies\n<\/p>\n<p>\n2.4.2 Diagnosed Prevalent Cases of Cardiomyopathies by Subtype\n<\/p>\n<p>\n2.4.3 Age-Specific Diagnosed Prevalent Cases of Cardiomyopathies\n<\/p>\n<p>\n2.4.4 Sex-Specific Diagnosed Prevalent Cases of Cardiomyopathies\n<\/p>\n<p>\n2.4.5 Diagnosed Prevalent Cases of Cardiomyopathies by Etiology\n<\/p>\n<p>\n2.4.6 Diagnosed Prevalent Cases of Dilated Cardiomyopathy with Ischemia\n<\/p>\n<p>\n2.5 Discussion\n<\/p>\n<p>\n2.5.1 Epidemiological Forecast Insight\n<\/p>\n<p>\n2.5.2 COVID-19 Impact\n<\/p>\n<p>\n2.5.3 Limitations of the Analysis\n<\/p>\n<p>\n2.5.4 Strengths of the Analysis\n<\/p>\n<p>\n<strong>3 Appendix<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5632229\/cardiomyopathies-epidemiology-forecast-2021-2031?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=zxbcdd&amp;utm_campaign=1727949+-+Cardiomyopathies+Epidemiology+Forecasts%2FAnalysis+Report+2021-2031%3A+Focus+on+United+States%2C+France%2C+Germany%2C+Italy%2C+Spain%2C+UK%2C+and+Japan&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/b1efe2<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"mail&#116;&#111;&#58;&#112;&#114;&#101;&#115;&#x73;&#x40;&#x72;&#x65;&#x73;&#x65;&#x61;&#x72;&#x63;hand&#109;&#97;&#114;&#107;&#101;&#116;&#115;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;r&#x65;s&#x73;&#64;&#x72;&#101;&#x73;&#101;&#x61;&#114;c&#x68;a&#x6e;d&#x6d;&#97;&#x72;&#107;&#x65;&#116;&#x73;&#46;c&#x6f;m<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Cardiomyopathies Epidemiology Forecast, 2021-2031&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report includes a 10-year epidemiological forecast for the diagnosed prevalent cases of these cardiomyopathies segmented by subtype, sex, and age (under 18 years, 18-29 years, and by 10-year age groups for ages 30 years up to 80 years and older) in &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46302","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cardiomyopathies Epidemiology Forecasts\/Analysis Report 2021-2031: Focus on United States, France, Germany, Italy, Spain, UK, and Japan - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cardiomyopathies Epidemiology Forecasts\/Analysis Report 2021-2031: Focus on United States, France, Germany, Italy, Spain, UK, and Japan - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Cardiomyopathies Epidemiology Forecast, 2021-2031&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report includes a 10-year epidemiological forecast for the diagnosed prevalent cases of these cardiomyopathies segmented by subtype, sex, and age (under 18 years, 18-29 years, and by 10-year age groups for ages 30 years up to 80 years and older) in ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-19T10:01:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220719005671\/en\/1517453\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Cardiomyopathies Epidemiology Forecasts\\\/Analysis Report 2021-2031: Focus on United States, France, Germany, Italy, Spain, UK, and Japan &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-07-19T10:01:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\\\/\"},\"wordCount\":603,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220719005671\\\/en\\\/1517453\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\\\/\",\"name\":\"Cardiomyopathies Epidemiology Forecasts\\\/Analysis Report 2021-2031: Focus on United States, France, Germany, Italy, Spain, UK, and Japan - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220719005671\\\/en\\\/1517453\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-07-19T10:01:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220719005671\\\/en\\\/1517453\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220719005671\\\/en\\\/1517453\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cardiomyopathies Epidemiology Forecasts\\\/Analysis Report 2021-2031: Focus on United States, France, Germany, Italy, Spain, UK, and Japan &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cardiomyopathies Epidemiology Forecasts\/Analysis Report 2021-2031: Focus on United States, France, Germany, Italy, Spain, UK, and Japan - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Cardiomyopathies Epidemiology Forecasts\/Analysis Report 2021-2031: Focus on United States, France, Germany, Italy, Spain, UK, and Japan - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Cardiomyopathies Epidemiology Forecast, 2021-2031&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report includes a 10-year epidemiological forecast for the diagnosed prevalent cases of these cardiomyopathies segmented by subtype, sex, and age (under 18 years, 18-29 years, and by 10-year age groups for ages 30 years up to 80 years and older) in ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-19T10:01:58+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220719005671\/en\/1517453\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Cardiomyopathies Epidemiology Forecasts\/Analysis Report 2021-2031: Focus on United States, France, Germany, Italy, Spain, UK, and Japan &#8211; ResearchAndMarkets.com","datePublished":"2022-07-19T10:01:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/"},"wordCount":603,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220719005671\/en\/1517453\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/","name":"Cardiomyopathies Epidemiology Forecasts\/Analysis Report 2021-2031: Focus on United States, France, Germany, Italy, Spain, UK, and Japan - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220719005671\/en\/1517453\/21\/logo.jpg","datePublished":"2022-07-19T10:01:58+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220719005671\/en\/1517453\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220719005671\/en\/1517453\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cardiomyopathies-epidemiology-forecasts-analysis-report-2021-2031-focus-on-united-states-france-germany-italy-spain-uk-and-japan-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cardiomyopathies Epidemiology Forecasts\/Analysis Report 2021-2031: Focus on United States, France, Germany, Italy, Spain, UK, and Japan &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46302","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46302"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46302\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46302"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46302"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46302"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}